8.5 | | Ccn2 | 'confluent monolayer on collagen' at '7 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
8.2 | | Ccn2 | 'subconfluent monolayer on collagen' at '5 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
8.1 | | Ccn2 | 'subconfluent monolayer on collagen' at '7 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-8 | | Ccn2 | 'acute graft vs. host disease; T-cell depleted bone marrow + T cells transplant' vs 'normal; T-cell depleted bone marrow transplant' | disease, stimulus | RNA-Seq of lymph node fibroblastic reticular cells isolated from bone marrow transplant recipient mice with or without acute Graft-versus-host disease on day 7 or untransplanted control mice |
8 | | Ccn2 | 'confluent monolayer on collagen' at '5 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
7.9 | | Ccn2 | 'subconfluent monolayer on collagen' at '3 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
7.8 | | Ccn2 | 'subconfluent monolayer on collagen' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
7.6 | | Ccn2 | 'confluent monolayer on collagen' at '3 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
7.5 | | Ccn2 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'bone marrow macrophage from 129P2 mouse strain' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
7 | | Ccn2 | 'confluent monolayer on collagen' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
6.8 | | Ccn2 | 'neurosphere in differentiation medium; 12 day' vs 'neurosphere; 0 day' in 'wild type genotype' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
6.6 | | Ccn2 | 'collagen sandwich' at '7 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-6.3 | | Ccn2 | 'CpG; 6 hour' vs 'none; 0 hour' in 'none' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
6.3 | | Ccn2 | 'hepatocyte-derived proliferative ducts (hepPDs)' vs 'hepatocyte' | cell type | Transcription profiling by high throughput sequencing of hepatocyte-derived progenitors cells in a mouse model of oval cell activation |
-6.3 | | Ccn2 | 'mutant MyoD expression' at '12 hour' vs 'wild type MyoD expression' at '0 hour' | phenotype, time | Transcription profiling of mouse embryoic fibroblasts expressing wild type MyoD or its non-acetylatable version MyoD RRR to investigate how MyoD acetylation may contribute to differential gene activation. |
6.3 | | Ccn2 | 'confluent monolayer on collagen' at '1 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
6.2 | | Ccn2 | 'neurosphere in differentiation medium; 12 day' vs 'neurosphere; 0 day' in 'Cstb knockout' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
-6.2 | | Ccn2 | 'mutant MyoD expression' at '24 hour' vs 'wild type MyoD expression' at '0 hour' | phenotype, time | Transcription profiling of mouse embryoic fibroblasts expressing wild type MyoD or its non-acetylatable version MyoD RRR to investigate how MyoD acetylation may contribute to differential gene activation. |
6.1 | | Ccn2 | 'Lgr6-positive hair follicle/sebaceous gland cell' vs 'Lgr6-positive basal interfollicular epidermis cell' | cell type | Transcription profiling of Lgr6+ keratinocyte populations in the epidermis and hair follicle |
6.1 | | Ccn2 | 'collagen sandwich' at '3 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-6 | | Ccn2 | 'induced neural stem cell' vs 'mouse embryonic fibroblast cell' | cell type | Gene expression profile of mouse induced neural stem cells |
-6 | | Ccn2 | 'Zbtb10 knockdown' vs 'control' at '2 hour' | genotype, time | RNA-seq of Zbtb10 Knockdown and Control cDC1 dendritic cells (Cd8+) |
-5.6 | | Ccn2 | '21 percent oxygen, 37 degree Celsius, no serum' vs 'none' | growth condition | RNA sequencing of native and ex vivo cultured murine tail tendon fascicles |
-5.6 | | Ccn2 | 'SMRT shRNA; CpG; 6 hour' vs 'none; none; 0 hour' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
-5 | | Ccn2 | 'neuron' vs 'differentiating progenitor' | cell type | Transcription profiling by high throughput sequencing of proliferating neural stem cells, differentiating neurogenic progenitors and newborn neurons using a dual-reporter mouse line |
-5 | | Ccn2 | 'mutant MyoD expression' at '6 hour' vs 'wild type MyoD expression' at '0 hour' | phenotype, time | Transcription profiling of mouse embryoic fibroblasts expressing wild type MyoD or its non-acetylatable version MyoD RRR to investigate how MyoD acetylation may contribute to differential gene activation. |
4.7 | | Ccn2 | "muscularis externa layer of small intestine" vs "lamina propria of small intestine" in "YFP negative" | organism part, phenotype | Bulk RNA-sequencing of self-maintaining versus monocyte-replaced gut macrophages |
4.3 | | Ccn2 | 'Plasmodium chabaudi infection' vs 'no infection' in 'adjuvant only' | infect, treatment | Protective vaccination against blood-stage malaria of Plasmodium chabaudi: differential gene expression in the liver of Balb/c mice towards the end of crisis phase |
-4 | | Ccn2 | '21 percent oxygen, 37 degree Celsius, 10 percent serum' vs 'none' | growth condition | RNA sequencing of native and ex vivo cultured murine tail tendon fascicles |
4 | | Ccn2 | 'neurosphere in differentiation medium; 5 day' vs 'neurosphere; 0 day' in 'wild type genotype' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
3.9 | | Ccn2 | 'clear cell sarcoma; Rosa26CreER' vs 'control' | disease, genotype | Mouse Model of Clear Cell Sarcoma |
3.9 | | Ccn2 | 'seizure-preconditioning followed by intra-amygdala kainic acid' vs 'sham-preconditioning followed by intra-amygdala vehicle' | clinical treatment | Transcription profiling by array of mice with epileptic tolerance |
-3.8 | | Ccn2 | 'CpG; 6 hour' vs 'none; 0 hour' in 'SMRT shRNA' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
3.8 | | Ccn2 | 'sham-preconditioning followed by intra-amygdala kainic acid' vs 'sham-preconditioning followed by intra-amygdala vehicle' | clinical treatment | Transcription profiling by array of mice with epileptic tolerance |
3.8 | | Ccn2 | 'collagen sandwich' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.7 | | Ccn2 | 'Lin- Dapi-EpCAM- CD31+td-tomato+' vs 'Lin- Dapi-EpCAM- CD31+td-tomato-' in 'vascular endothelial cell' | cell type, phenotype | Thymic T-cell progenitor development is supported by membrane bound Kit ligand provided by a combined vascular endothelial and epithelial niche. |
3.6 | | Ccn2 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'derived macrophage from E14 cell line' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
-3.6 | | Ccn2 | '70 week' vs '6 week' in 'none; none; | age, irradiate | Pericyte induced reprogramming of the bone marrow microenvironment drives stem and cancer cell quiescence |
3.6 | | Ccn2 | 'antibiotics, CCl4 and diethylnitrosamine' vs 'none' in 'wild type genotype' | genotype, treatment | Gene expression accompanying the promotion of hepatocellular carcinoma by intestinal microbiota and Tlr4 in mice. |
3.6 | | Ccn2 | 'Plasmodium chabaudi infection' vs 'no infection' in 'vaccination' | infect, treatment | Protective vaccination against blood-stage malaria of Plasmodium chabaudi: differential gene expression in the liver of Balb/c mice towards the end of crisis phase |
3.6 | | Ccn2 | 'Taf10-/-' vs 'wild type' | genotype | Transcription profiling by array of liver from Taf10 knock out mice |
3.5 | | Ccn2 | 'infarct and border region of left ventricle 5 days post-myocardial infarction; C57BL/6J' vs 'left ventricle at baseline (no myocardial infarction) in the same region as the infarct in post-myocardial infarction hearts; C57BL/6J' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
3.4 | | Ccn2 | '336 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine J1 embryonic stem cells undergoing a differentiation time course to study changes in transcription during stem cell differentiation |
-3.4 | | Ccn2 | '3D culture' vs '2D culture' | growth condition | mRNA-seq of mouse salivary gland cancer cells cultured in adherent or non-adherent culture |
3.4 | | Ccn2 | 'neurosphere in differentiation medium; 5 day' vs 'neurosphere; 0 day' in 'Cstb knockout' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
-3.4 | | Ccn2 | '4 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
3.3 | | Ccn2 | 'undifferentiated' vs 'differentiated; rosiglitazone' in '129S6sv/ev' | phenotype, stimulus, strain | RNA-seq of mouse subcutaneous SVF cells before and after differentiation with a brown fat differentiation cocktail |
-3.3 | | Ccn2 | 'organoid culture without Noggin (ER medium)' vs 'organoid culture (ENR medium)' in 'none' | growth condition, stimulus | RNA-seq of small intestinal organoids treated with the control medium ENR (EGF, Noggin, R-spondin1) in the presence or absence of muscle supernatant |
-3.3 | | Ccn2 | 'Ngn3-expressing cell' vs 'Ngn3-null cell' | cell type | Transcriptional profiling of Ngn3-dependent pancreatic endocrine differentiation at E15.5 |
-3.3 | | Ccn2 | '5 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
3.3 | | Ccn2 | 'infarct and border region of left ventricle 1 day post-myocardial infarction; C57BL/6J' vs 'left ventricle at baseline (no myocardial infarction) in the same region as the infarct in post-myocardial infarction hearts; C57BL/6J' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
-3.3 | | Ccn2 | 'wild type; mature luminal' vs 'wild type; MaSC/basal' | cell type, genotype | Expression data from sorted control and Pygo2-null mouse mammary stem/basal cells |
3.3 | | Ccn2 | 'trichostatin A and LIF' at '12 hour' vs 'none' at '0 hour' | compound, time | Transcription profiling of mouse embryonic stem cell line CGR8 grown in presence of Leukemia Inhibitory Factor and treated with trichostatin A |
3.2 | | Ccn2 | 'high fat diet; 30 degree celsius' vs 'chow; 23 degree celsius' in 'brown adipose tissue' | diet, organism part, temperature | RNA-seq of brown and white mouse adipose tissue at thermoneutrality and high-fat diet |
3.2 | | Ccn2 | 'human-Mfn2 T111A/S442A-overexpressing (Mfn2AA)' vs 'tet-off control' in '5 week; left ventricle' | age, genotype, organism part | Transcription profiling by high throughput sequencing of a mitofusin 2 (Mfn2) mutant in mouse |
3.2 | | Ccn2 | 'extraembryonic endoderm stem cell; grown in ES cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
-3.2 | | Ccn2 | '3 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
3.1 | | Ccn2 | '216 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine J1 embryonic stem cells undergoing a differentiation time course to study changes in transcription during stem cell differentiation |
3.1 | | Ccn2 | 'induced extraembryonic endoderm stem cell; grown in XEN cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
-3.1 | | Ccn2 | 'damaged by neuropathy' vs 'control' | sampling site | Transcriptional profiling of damaged and adjacent but intact dorsal root ganglia neurons against DRG cells from contralacteral control regions from mice with neuropathy |
3 | | Ccn2 | 'CD36 knockout' vs 'wild type genotype' in 'oxidized low density lipoprotein; 25 microgram per milliliter' | compound, genotype | Quantitative analysis of wild type and cd36-/- murine peritoneal macrophage transcriptomes |
3 | | Ccn2 | '14 day' vs '0 day' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine R1 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
3 | | Ccn2 | 'colitis' at '8 day' vs 'normal' at '0 day' | disease, time | Temporal transcriptomic changes during DSS colitis development and resolution. |
3 | | Ccn2 | '96 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine J1 embryonic stem cells undergoing a differentiation time course to study changes in transcription during stem cell differentiation |
3 | | Ccn2 | 'high fat diet' vs 'regular chow diet' in 'wild type genotype' | diet, genotype | Transcription profiling by array of liver tissues from mice with liver-specific knockout of Pit1 and wild-type littermates fed with either a high-fat diet or chow control diet |
3 | | Ccn2 | 'Alb-Cre;VHLf/f' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
2.9 | | Ccn2 | 'induced extraembryonic endoderm stem cell; grown in ES cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
2.9 | | Ccn2 | 'human-Mfn2 T111A/S442A-overexpressing (Mfn2AA)' vs 'wild type' in '5 week; left ventricle' | age, genotype, organism part | Transcription profiling by high throughput sequencing of a mitofusin 2 (Mfn2) mutant in mouse |
2.9 | | Ccn2 | 'transforming growth factor beta 1' vs 'none' at '6 day' | stimulus, time | Experimental overactivity or blockade of transforming growth factor-B each generate a specific ureter malformation |
2.9 | | Ccn2 | 'non-infarct region of left ventricle 1 day post-myocardial infarction; C57BL/6J' vs 'left ventricle at baseline (no myocardial infarction) in the same region as non-infarct tissue in post-myocardial infarction hearts; C57BL/6J' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
2.9 | | Ccn2 | 'transgenic C3(1)-SV40Tag; 20 week' vs 'wild type; 8 week' | age, genotype | Prevention of mammary tumor progression by silencing HoxA1 via intraductal injection of nanoparticle-formulated siRNA |
-2.9 | | Ccn2 | 'Ink4a/Arf-/-; EGFRvIII' vs 'wild type genotype' in 'co-culture' | genotype, growth condition | RNA-seq of wild-type and transformed Ink4a/Arf-/-; EGFRvIII neural stem cells in separate or co-culture conditions |
2.9 | | Ccn2 | 'CD34+ keratinocyte' vs 'CD34-keratinocyte' | cell type | Akt signalling leads to stem cell activation and promotes tumour development in epidermis. |
2.9 | | Ccn2 | 'CCl4 and diethylnitrosamine' vs 'none' in 'wild type genotype' | genotype, treatment | Gene expression accompanying the promotion of hepatocellular carcinoma by intestinal microbiota and Tlr4 in mice. |
2.9 | | Ccn2 | '20 day; Ad-VEGF-A164' vs '0 day; control' | time, treatment | Transcription profiling by array of stromal-based signatures for the classification of gastric cance |
-2.8 | | Ccn2 | 'Irx3 knockout' vs 'control' at '1 day' | genetic modification, time | RNA-Seq of mouse Irx3-KO and Control ME3 cells on days 1 and 7 of adipogenic differentiation |
-2.8 | | Ccn2 | 'Irx3 knockout' vs 'control' at '7 day' | genetic modification, time | RNA-Seq of mouse Irx3-KO and Control ME3 cells on days 1 and 7 of adipogenic differentiation |
2.8 | | Ccn2 | 'N-acetylcysteine; 4 day differentiated; 1 millimolar' vs 'none; 4 day differentiated' | compound, developmental stage | RNA-seq of C17.2 neuronal progenitor cells exposed to cerium oxide nanoparticles during cell differentiation |
2.8 | | Ccn2 | 'undifferentiated' vs 'differentiated; rosiglitazone' in 'C57BL/6J' | phenotype, stimulus, strain | RNA-seq of mouse subcutaneous SVF cells before and after differentiation with a brown fat differentiation cocktail |
2.8 | | Ccn2 | 'infarct and border region of left ventricle 5 days post-myocardial infarction; MRL/MpJ' vs 'left ventricle at baseline (no myocardial infarction) in the same region as the infarct in post-myocardial infarction hearts; MRL/MpJ' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
2.8 | | Ccn2 | 'tumor' vs 'normal' in 'liver' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
2.8 | | Ccn2 | 'Alb-Cre;HIF1dPA/HIF2dPA' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
2.8 | | Ccn2 | 'heart; 1 day' vs 'heart; 0 day' | organism part, time | Expression data from mouse tissue Angiotensin II treated for 0,1,3,7days |
2.8 | | Ccn2 | 'non-infarct region of left ventricle 5 days post-myocardial infarction; C57BL/6J' vs 'left ventricle at baseline (no myocardial infarction) in the same region as non-infarct tissue in post-myocardial infarction hearts; C57BL/6J' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
2.7 | | Ccn2 | 'Tgfbeta 1 ligand 0.04 nanogram per milliliter' vs 'none' | compound | Expression data from intestinal organoids altered for Tgfbeta signaling |
2.7 | | Ccn2 | 'undifferentiated' vs 'differentiated; rosiglitazone' in 'A/J' | phenotype, stimulus, strain | RNA-seq of mouse subcutaneous SVF cells before and after differentiation with a brown fat differentiation cocktail |
2.7 | | Ccn2 | 'methionine- and choline-deficient, high fat diet' vs 'normal' | diet | Expression data from mouse liver treated with metformin |
2.7 | | Ccn2 | 'postnatal >1 year; hindlimb' vs 'embryonic day 17.5; whole forelimb and hindlimb' | age, organism part | Expression data from skeletal muscle satellite cells at different development stages |
-2.7 | | Ccn2 | 'total RNA; HRasV12 and c-Myc overexpression and Eif4e wild type' vs 'total RNA; wild type' | fraction, genotype | Redefining the role of eIF4E dose in development, cancer, and protein synthesis |
-2.7 | | Ccn2 | 'polysomal RNA; HRasV12 and c-Myc overexpression and Eif4e wild type' vs 'polysomal RNA; wild type' | fraction, genotype | Redefining the role of eIF4E dose in development, cancer, and protein synthesis |
2.7 | | Ccn2 | 'neurosphere in differentiation medium; 1 day' vs 'neurosphere; 0 day' in 'wild type genotype' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
-2.6 | | Ccn2 | 'PF-04691502–resistant cell; 1 micromolar; PF-04691502 removed for 48 hours' vs 'parental AKP cell; dimethyl sulfoxide' | compound, phenotype | Resistance to PI3K/mTOR inhibitor PF-04691502 in KRAS mutant colorectal cancer models reveals a sensitivity to combination with EGFR inhibition |
2.6 | | Ccn2 | 'infarct and border region of left ventricle 1 day post-myocardial infarction; MRL/MpJ' vs 'left ventricle at baseline (no myocardial infarction) in the same region as the infarct in post-myocardial infarction hearts; MRL/MpJ' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
2.6 | | Ccn2 | 'ko cyld-/-' vs 'wild type' | genotype | Transcription profiling by array of mouse liver with Cyld inactivation |
2.6 | | Ccn2 | 'undifferentiated' vs 'differentiated; rosiglitazone' in 'SWR/J' | phenotype, stimulus, strain | RNA-seq of mouse subcutaneous SVF cells before and after differentiation with a brown fat differentiation cocktail |
2.6 | | Ccn2 | 'uterine-specific Tsc2-null' vs 'wild type' in 'intact' | genotype, treatment | Transcription profiling by high throughput sequencing of uterine-specific Tsc2-null mice |
2.6 | | Ccn2 | 'p48-Cre;KrasG12D;Ela-Tgfa' vs 'wild type' | genotype | Transcription profiling by array of pancreas from KrasG12D, Ela-Tgfa and KrasG12D Ela-Tgfa mice |
2.6 | | Ccn2 | 'aortic banding' at '24 hour' vs 'sham' at '24 hour' | injury, time | Transcription profiling of heart ventricles from mice at different time points after surgical intervention for pressure-overload induced hypertrophy to identify differentially expressed genes. |
2.6 | | Ccn2 | '5 day; Ad-VEGF-A164' vs '0 day; control' | time, treatment | Transcription profiling by array of stromal-based signatures for the classification of gastric cance |
-2.5 | | Ccn2 | 'doxorubicin; 17.5 milligram per kilogram body weight' vs 'vehicle' in 'scramble; podocyte' | cell type, compound, genotype | Transcription profiling to identify the role of MOF in primary MEFs and differentiated podocytes in response to Adriamycin |
2.5 | | Ccn2 | 'TGFβ, 5 nanogram per milliliter' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
2.5 | | Ccn2 | 'extraembryonic endoderm stem cell; grown in XEN cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
2.5 | | Ccn2 | 'diet restriction' vs 'control' | diet | Liver mRNA microarray study for mice treated with various diets |
2.5 | | Ccn2 | 'mutant MyoD expression' at '6 hour' vs 'control' at '6 hour' | phenotype, time | Transcription profiling of mouse embryoic fibroblasts expressing wild type MyoD or its non-acetylatable version MyoD RRR to investigate how MyoD acetylation may contribute to differential gene activation. |
2.5 | | Ccn2 | 'glioblastoma multiforme' vs 'normal' | disease | Analysis of the expression profiles of glioma-associated microglia/macrophages and naive control cells in Mus musculus. |
2.5 | | Ccn2 | 'alphaMHC-Cre+/0;MAT1F/F' vs 'alphaMHC-Cre+/0;MAT1F/+' in '4 week' | age, genotype | Transcription profiling of mouse heart from cardiac-specific conditional knockout deletion of menage-a-trios-1 (MAT1) |
-2.5 | | Ccn2 | 'SGC-CBP30; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.5 | | Ccn2 | 'PDE10 inhibitor; PDE10A knockout; striatum' vs 'PDE10 inhibitor; wild type; striatum' | compound, genotype, organism part | Microarray profiling of WT or PDE10A KO mice treated with vehicle or a PDE10 inhibitor |
2.4 | | Ccn2 | 'shear stressing' vs 'none' | stimulus | RNA seq of fluid shear stress treated mouse renal epithelial cells |
2.4 | | Ccn2 | 'shear stressing' vs 'none' | stimulus | RNA seq of fluid shear stress treated mouse Pkd1-/- renal epithelial cells |
2.4 | | Ccn2 | 'Gata3 knock out' vs 'wild type' | genotype | Transcription profiling by array of Gata3 knock-out mice |
2.4 | | Ccn2 | 'dexamethasome' vs 'methyl beta-clodextrin' in 'Nr1d1 homozygous knockout; 1 milligram per kilogram; ZT6' | compound, genotype, time | RNASeq data analysis of wild type and reverb alpha knockout cells from mouse liver, at different time points, with or without DEX treatment |
-2.4 | | Ccn2 | 'total RNA; HRasV12 and c-Myc overexpression and Eif4e heterozygous knockout' vs 'total RNA; wild type' | fraction, genotype | Redefining the role of eIF4E dose in development, cancer, and protein synthesis |
-2.4 | | Ccn2 | 'PFI-1; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.3 | | Ccn2 | 'SR-BI-/- apoE-/-' vs 'control' in '43 day; Chow diet' | age, diet, genotype | Expression data from the hearts of a mouse model of spontaneous myocardial infarction |
2.3 | | Ccn2 | 'postnatal 2-3 month; hindlimb' vs 'embryonic day 17.5; whole forelimb and hindlimb' | age, organism part | Expression data from skeletal muscle satellite cells at different development stages |
2.3 | | Ccn2 | 'SARS coronavirus MA15' vs 'none' at '2 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
2.3 | | Ccn2 | '1,2-Dibromoethane; 62 milligram per kilogram; corn oil' vs 'none; ; corn oil' | compound, treatment | Transcription profiling by array of Mus musculus liver tissue after exposure to various carcinogenic chemicals |
-2.3 | | Ccn2 | 'lipopolysaccharide; 10 nanogram per milliliter and SGC-CBP30; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.2 | | Ccn2 | 'non-infarct region of left ventricle 5 days post-myocardial infarction; MRL/MpJ' vs 'left ventricle at baseline (no myocardial infarction) in the same region as non-infarct tissue in post-myocardial infarction hearts; MRL/MpJ' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
-2.2 | | Ccn2 | 'Insm1-expressing endocrine progenitor cell' vs 'Insm1-lacking endocrine progenitor cell' in 'embryonic day 15.5' | cell type, developmental stage | Transcriptional regulation of endocrine cell differentiation by Insm1 |
-2.2 | | Ccn2 | '7 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
2.2 | | Ccn2 | 'SARS coronavirus MA15' vs 'none' at '2 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
2.2 | | Ccn2 | 'Dmd-mdx mutation' vs 'wild type genotype' in 'none' | compound, genotype | RNA-seq comparison of fibro-adipogenic progenitors (FAPs) from wild type, mdx and cardiotoxin-injured mice |
2.2 | | Ccn2 | 'osteosarcoma' vs 'control' | disease, genotype | Mouse Model of Clear Cell Sarcoma |
2.2 | | Ccn2 | 'TAC surgery' vs 'sham surgery' in 'C57BL/6N' | strain, treatment | Transcription profiling of left ventricular myocardium after sham or TAC surgery in BL/6N and BL/6J mice |
2.2 | | Ccn2 | 'Alb-Cre;HIF2dPA' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
2.2 | | Ccn2 | 'Lgr6-positive hair follicle/sebaceous gland cell' vs 'basal keratinocyte' | cell type | Transcription profiling of Lgr6+ keratinocyte populations in the epidermis and hair follicle |
-2.2 | | Ccn2 | 'lipopolysaccharide; 10 nanogram per milliliter and PFI-1; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.1 | | Ccn2 | 'N-acetylcysteine; 7 day differentiated; 1 millimolar' vs 'none; 7 day differentiated' | compound, developmental stage | RNA-seq of C17.2 neuronal progenitor cells exposed to cerium oxide nanoparticles during cell differentiation |
2.1 | | Ccn2 | 'liver-specific Cnot3 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
2.1 | | Ccn2 | 'liver-specific Cnot1 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
-2.1 | | Ccn2 | '3 day; myogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn378' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
-2.1 | | Ccn2 | '6 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
2.1 | | Ccn2 | 'SARS coronavirus MA15' vs 'mock' in 'TLR3 knockout' at '2 day' | genotype, infect, time | Mouse lung tissue transcriptome response to a mouse-adapted strain of SARS-CoV in wild type C57BL6/NJ mice and TLR3-/- mice |
2.1 | | Ccn2 | 'SARS coronavirus MA15; 10^5 PFU' vs 'none' at '2 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
2.1 | | Ccn2 | '1 hour after induction of differentiation' vs 'induction of differentiation' | compound, sampling time point | Expression Profiling of Early Myogenesis - Affymetrix Dataset |
2.1 | | Ccn2 | 'fear conditioning' vs 'none' | stimulus | Gene-expression changes in neurons active during contextual fear conditioning compared to controls left in the homecage |
2.1 | | Ccn2 | '1.5 hour after induction of differentiation' vs 'induction of differentiation' | compound, sampling time point | Expression Profiling of Early Myogenesis - Affymetrix Dataset |
2.1 | | Ccn2 | 'CCl4; 1.6 gram per kilogram' at '24 hour' vs 'none' at '0 hour' | compound, time | Transcriptional responses in liver upon acute CCl4 intoxication |
2.1 | | Ccn2 | 'cardiotoxin; 10 micromolar' vs 'none' in 'wild type genotype' | compound, genotype | RNA-seq comparison of fibro-adipogenic progenitors (FAPs) from wild type, mdx and cardiotoxin-injured mice |
-2.1 | | Ccn2 | 'liver-specific Pit1 knockout' vs 'wild type genotype' in 'high fat diet' | diet, genotype | Transcription profiling by array of liver tissues from mice with liver-specific knockout of Pit1 and wild-type littermates fed with either a high-fat diet or chow control diet |
2.1 | | Ccn2 | '48 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine J1 embryonic stem cells undergoing a differentiation time course to study changes in transcription during stem cell differentiation |
2.1 | | Ccn2 | 'epithelium-specific Apc knockout' vs 'wild type' | phenotype | RNAseq of murine small intestinal tissue following epithelium-specific deletion of Bcl9/9l +/- Apc +/- mutant B-catenin |
-2.1 | | Ccn2 | 'Pcl2 knockdown' vs 'control' | genotype | Gene expression profile in mouse embryonic stem cells in which endogenous Pcl2 expression was stably knocked down using short hairpin RNA |
-2.1 | | Ccn2 | 'FusΔNLS/+' vs 'wild type genotype' at '12 hour' | genotype, time | Mutant FUS triggers age-dependent synaptic impairment in presymptomatic ALS-FUS mice (RNA-seq part2) |
2.1 | | Ccn2 | 'liver-specific Gp130 knockout mice [Gp130delta(hepa)]; cecal ligation and puncture' vs 'liver-specific Gp130 knockout mice [Gp130delta(hepa)]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
2 | | Ccn2 | 'N-acetylcysteine; 1 day differentiated; 1 millimolar' vs 'none; 1 day differentiated' | compound, developmental stage | RNA-seq of C17.2 neuronal progenitor cells exposed to cerium oxide nanoparticles during cell differentiation |
2 | | Ccn2 | 'carotid body' vs 'adrenal medulla' | organism part | Expression profile of mouse carotid body and adrenal medulla [RNA-Seq] |
2 | | Ccn2 | '3 day; osteogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn0' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
2 | | Ccn2 | '5-aza-2'-deoxycytidine; 5 micromolar' vs 'none' | compound | Transcription profiling by array of mouse primary dermal fibroblasts after treatment with 5-aza-2'-deoxycytidine |
2 | | Ccn2 | 'wild type; SARS MA15; 2 day' vs 'wild type; mock' | genotype, infect, time | Infection of wild type and CXCR3 knockout C57BL6/J mice with SARS MA15 |
-2 | | Ccn2 | 'extracellular vesicle; non-stimulated culture medium' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
2 | | Ccn2 | '168 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine J1 embryonic stem cells undergoing a differentiation time course to study changes in transcription during stem cell differentiation |
2 | | Ccn2 | 'cardiac-specific constitutive expression of an activated Akt (caAkt)' vs 'wild type genotype' | genotype | Transcription profiling by array of cardic ventricle tissues from mice with cardiac-specific constitutive expression of an activated Akt (caAkt) and wild-type controls to test whether Akt activation contributes to mitochondrial dysfunction in pathological cardiac hypertrophy |
-2 | | Ccn2 | 'oral hard palate epithelium' vs 'tail skin epithelium' | organism part | Transcriptional profiling of mouse oral and skin epithelium to study their intrinsic difference in global gene expression |
2 | | Ccn2 | 'SARS coronavirus MA15 dORF6' vs 'none' at '2 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
2 | | Ccn2 | 'tamoxifen induction at 2 months, wait 6 months' vs 'no tamoxifen induction' in 'basal cell of prostate epithelium; CK5-CreERT2 transgenic line' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
2 | | Ccn2 | 'methionine- and choline-deficient, high fat diet mixed with 0.1% metformin' vs 'normal' | diet | Expression data from mouse liver treated with metformin |
-2 | | Ccn2 | 'E-FABP knockout' vs 'wild type' | genotype | Gene expression microarray data of bone marrow derived macrophages using GM-CSF(GM-BMMs) co-cultured with E0771 breast tumor cells |
2 | | Ccn2 | 'eNOS knockout' vs 'wild type' | genotype | Transcription profiling by array of left ventricles from eNOS knock-out mice |
-1.9 | | Ccn2 | 'co-cultured with hematopoietic stem cell for 9 days' vs 'non co-cultured for 9 days' in 'endothelial cell; expressing AKT1' | cell type, growth condition, phenotype | Transcription profiling by high throughput sequencing of murine bone marrow endothelial cells and bone marrow stroma, in vitro and in vivo, with and without hematopoietic stem cells co-culture |
-1.9 | | Ccn2 | 'dexamethasone; 100 nanomolar; interferon gamma' vs 'none' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
-1.9 | | Ccn2 | 'SMRT shRNA' vs 'none' in 'none' at '0 hour' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
-1.9 | | Ccn2 | 'doxycycline-induced expression of NGN3' vs 'control' at '48 hour' | time, treatment | Transcription profiling by array of mouse embryonic stem cells expressing the transcription factor NGN3 for 12 hours, 24 hours and 48 hours |
1.9 | | Ccn2 | '4 day' vs '0 day' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine R1 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
1.9 | | Ccn2 | 'chronic pancreatitis' vs 'control' | disease | Pancreatic gene expression associated with cerulein induced chronic pancreatitis in mice |
1.9 | | Ccn2 | 'dexamethasome' vs 'methyl beta-clodextrin' in 'wild type genotype; 1 milligram per kilogram; ZT6' | compound, genotype, time | RNASeq data analysis of wild type and reverb alpha knockout cells from mouse liver, at different time points, with or without DEX treatment |
1.9 | | Ccn2 | 'oxygen/glucose-deprivation followed by restoration of oxygen/glucose' vs 'none' in 'wild type genotype; undifferentiated' | genotype, growth condition, stimulus | SUMOylation promotes survival and integration of neural stem cell grafts in stroke |
-1.9 | | Ccn2 | 'miR-1-133a_FGFR1_tKO' vs 'miR-1-133a_dKO' | compound, genotype | Repression of OSMR and FGFR1 by miR-1/133a prevents adult cardiomyocyte dedifferentiation and cell cycle entry in the adult heart |
1.9 | | Ccn2 | 'non-infarct region of left ventricle 1 day post-myocardial infarction; MRL/MpJ' vs 'left ventricle at baseline (no myocardial infarction) in the same region as non-infarct tissue in post-myocardial infarction hearts; MRL/MpJ' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
-1.9 | | Ccn2 | 'carcinoma' vs 'normal' | disease | Gene expression profile between normal mouse skin and carcinomas arising in the skin of RbF/F;K14creERTM;p107-/- mouse |
-1.9 | | Ccn2 | 'high fat diet' vs 'chow diet' in 'SHP knockout' | genotype, growth condition | Transcription profiling of small heterodimer partner deficiency (SHP) knockout mice heart |
-1.9 | | Ccn2 | 'dox-induced over-expression of oncogenes for 5 days' vs 'untreated control' | phenotype | Temporal Transcriptional Profiling in response to cMYC and KrasG12D Expression and Inactivation in In Vitro Cultured Primary Mammary Epithelial Cells of Adult Virgin Mice |
1.9 | | Ccn2 | 'collagen sandwich' at '1 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
1.9 | | Ccn2 | 'SARS coronavirus MA15 nsp16 -/-' vs 'none' at '2 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
-1.9 | | Ccn2 | 'postnatal day 60' vs 'postnatal day 1' in 'insulin-expressing immature beta cell' | cell type, developmental stage | Transcription profiling by high throughput sequencing of murine beta cells at key stages of maturation |
1.9 | | Ccn2 | 'SARS coronavirus MA15' vs 'mock' | infect | Host responses contributing to the attenuation of severe acute respiratory syndrome coronaviruses missing E protein domains |
-1.9 | | Ccn2 | 'polysomal RNA; HRasV12 and c-Myc overexpression and Eif4e heterozygous knockout' vs 'polysomal RNA; wild type' | fraction, genotype | Redefining the role of eIF4E dose in development, cancer, and protein synthesis |
-1.9 | | Ccn2 | 'cecal ligation and puncture surgery; PPTA knockout' vs 'cecal ligation and puncture surgery; wild type' | clinical treatment, genotype | Gene expression profile in lung tissue 8 h after inducing polymicrobial sepsis in preprotachykinin-A (PPTA) knockout mice and wild type |
1.9 | | Ccn2 | 'unilateral ureteral obstruction' vs 'sham' in 'wild type' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
-1.9 | | Ccn2 | 'Bmi1-overexpressing lentiviral vector' vs 'empty vector control' | genotype | Control and Bmi1-overexpressing adult murine neural stem cells |
1.9 | | Ccn2 | 'aortic banding' at '168 hour' vs 'sham' at '168 hour' | injury, time | Transcription profiling of heart ventricles from mice at different time points after surgical intervention for pressure-overload induced hypertrophy to identify differentially expressed genes. |
-1.9 | | Ccn2 | 'CD47 knockdown; cell from embryoid body-like cluster’ vs 'wild type; endothelial' | cell line, cell type, genotype | CD47 Inhibits Self-renewal and Reprogramming by Regulating c-Myc and Other Stem Cell Transcription Factors |
1.9 | | Ccn2 | 'oxygen/glucose-deprivation followed by restoration of oxygen/glucose' vs 'none' in 'Ubc9 overexpression; undifferentiated' | genotype, growth condition, stimulus | SUMOylation promotes survival and integration of neural stem cell grafts in stroke |
1.8 | | Ccn2 | 'CD36 knockout' vs 'wild type genotype' in 'none' | compound, genotype | Quantitative analysis of wild type and cd36-/- murine peritoneal macrophage transcriptomes |
1.8 | | Ccn2 | '9 day' vs '0 day' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine R1 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
1.8 | | Ccn2 | '7 day' vs '0 day' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine R1 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
1.8 | | Ccn2 | 'Staphylococcus aureus Sanger476; 2 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.8 | | Ccn2 | 'heart; 7 day' vs 'heart; 0 day' | organism part, time | Expression data from mouse tissue Angiotensin II treated for 0,1,3,7days |
1.8 | | Ccn2 | 'AZD5069; 100 milligram per kilogram' vs 'none' | compound | RNA-seq to investigate differentially expressed genes in KPC mouse PDAC treated with CSF-1R small molecule inhibitor AZD7507 and/or the CXCR2 small molecule inhibitor AZD5069 |
-1.8 | | Ccn2 | 'MEF; transduced with NeuroD2 lentivirus' vs 'MEF; control' | cell line, treatment | Genetic and epigenetic determinants of neurogenesis and myogenesis [expression profiling] |
1.8 | | Ccn2 | 'SARS coronavirus MA15; 10^4 PFU' vs 'none' at '2 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
1.8 | | Ccn2 | 'heart; 3 day' vs 'heart; 0 day' | organism part, time | Expression data from mouse tissue Angiotensin II treated for 0,1,3,7days |
-1.8 | | Ccn2 | 'Trp53 knockout' vs 'wild type genotype' in 'Nutlin-3a; 10 micromolar' | compound, phenotype | Residual tumor suppressor activities of tumorigenic p53 mutants enhance survival under chemotherapy |
1.8 | | Ccn2 | 'aortic banding' at '4 hour' vs 'sham' at '4 hour' | injury, time | Transcription profiling of heart ventricles from mice at different time points after surgical intervention for pressure-overload induced hypertrophy to identify differentially expressed genes. |
1.8 | | Ccn2 | 'hepatocyte-specific Pten and Tgfbr2 knockout' vs 'wild type' | genotype | Hepatocyte-specific knockout of Pten and of Pten and Tgfbr2 in mice |
1.8 | | Ccn2 | 'neurosphere in differentiation medium; 1 day' vs 'neurosphere; 0 day' in 'Cstb knockout' | genotype, growth condition, time | Transcriptome analysis of neurospheres derived from Cstb-KO mouse embryo brains during differentiation |
1.7 | | Ccn2 | 'co-cultured with hematopoietic stem cell for 9 days' vs 'non co-cultured for 9 days' in 'stromal cell; expressing AKT1' | cell type, growth condition, phenotype | Transcription profiling by high throughput sequencing of murine bone marrow endothelial cells and bone marrow stroma, in vitro and in vivo, with and without hematopoietic stem cells co-culture |
1.7 | | Ccn2 | 'CXCR3 knockout; SARS MA15; 2 day' vs 'CXCR3 knockout; mock' | genotype, infect, time | Infection of wild type and CXCR3 knockout C57BL6/J mice with SARS MA15 |
1.7 | | Ccn2 | 'clear cell sarcoma; TATCre' vs 'control' | disease, genotype | Mouse Model of Clear Cell Sarcoma |
-1.7 | | Ccn2 | 'acute oropharyngeal candidiasis' vs 'healthy' in wild type mice | compound, disease, genotype, sex | Transcription profiling by array of antibody blockade of IL-17-family cytokines in immunity to acute murine oral mucosal candidiasis |
1.7 | | Ccn2 | 'fasted' vs 're-fed' in 'wild type genotype; Gabpa miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1.7 | | Ccn2 | 'PAI1 knockout; SARS MA15; 7 day' vs 'PAI1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
-1.7 | | Ccn2 | 'UO126; 0.2 milligram per kilogram; miR-1-133a_dKO' vs 'miR-1-133a_dKO' | compound, genotype | Repression of OSMR and FGFR1 by miR-1/133a prevents adult cardiomyocyte dedifferentiation and cell cycle entry in the adult heart |
1.7 | | Ccn2 | 'prednisolone; wild type' vs 'vehicle; wild type' | compound, genotype | Prednisolone-induced differential gene expression in liver of mice carrying the wild type or a dimerization-defective glucocorticoid receptor |
1.7 | | Ccn2 | 'unilateral ureteral obstruction' vs 'sham' in 'TIMP3 -/-' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
1.7 | | Ccn2 | 'Pten knockout' vs 'wild type' at '15 month' | genotype, time | Transcription profiling by array of Pten knockout liver cells of mouse |
-1.7 | | Ccn2 | 'oculomotor nucleus motor neurons' vs 'lumbar motor neurons' | cell type | Comparison of gene expression in motor pools with differential vulnerability in ALS |
-1.7 | | Ccn2 | '6 month; RXRa hepatic deficiency; male' vs '6 month; wild type; male' | age, genotype, sex | Transcription profiling of liver from wild type and RXR-alpha deficient matured and aged mcie |
1.7 | | Ccn2 | 'doxorubicin; 15 milligram per kilogram; wild type' vs 'none; ; wild type' | compound, genotype | Expression data from DOX(doxorubicin) -treated wild type or CHIP knockout C57BL/6J mice at day 5 |
-1.7 | | Ccn2 | 'dorsolateral nucleus motor neuron' vs 'lumbar motor neurons' | cell type | Comparison of gene expression in motor pools with differential vulnerability in ALS |
1.7 | | Ccn2 | 'paracetamol; 529 milligram per kilogram' vs 'vehicle' at '4 hour' | compound, time | Transcription profiling by array of CD1 mice after nontoxic and nonlethal hepatotoxic paracetamol administration |
-1.7 | | Ccn2 | 'side population cells' vs 'main population cells' in 'muscle' | cell type, organism part | Gene expression of side population and main population cells, isolated from adult murine skeletal muscle and bone marrow |
1.6 | | Ccn2 | 'Mettl6 knockout clone D1' vs 'wild type genotype' | genotype | METTL6 is a tRNA m3C methyltransferase that regulates translation and tumor cell proliferation |
1.6 | | Ccn2 | 'interleukin-22 (Mus Musculus); 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
1.6 | | Ccn2 | '0.45 micromolar; 5-fluourouracil' vs 'none' at '24 hour' | compound, time | Transcription profiling by array of mouse embryonic stem cells after treatment with 5-fluourouracil, methoxyacetic acid, monobutl phthalate, Penicillin G, retinoic acid or valproic acid |
-1.6 | | Ccn2 | '36 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine V6.5 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
-1.6 | | Ccn2 | 'NrlGFP positive' vs 'NrlGFP negative' | phenotype | Transcription profiling by array of photoreceptor precursor cells selected via cell surface antigen expression. |
-1.6 | | Ccn2 | '2 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
1.6 | | Ccn2 | 'tape stripping and oral administration of winged bean extract' vs 'tape stripping' | treatment | Transcription profiling by array of mouse dorsal skin after tape stripping and treatment with winged bean extract. |
1.6 | | Ccn2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'C57BL/6J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1.6 | | Ccn2 | 'hyperoxia' vs 'control' in 'male' | sex, stimulus | Transcription profiling by array of lung tissues from wild-type male and female C56BL/6J mice either maintained in room air or exposed to hyperoxia (FiO2>95%) for 48 hours |
1.6 | | Ccn2 | 'hyperoxia' vs 'control' in 'female' | sex, stimulus | Transcription profiling by array of lung tissues from wild-type male and female C56BL/6J mice either maintained in room air or exposed to hyperoxia (FiO2>95%) for 48 hours |
1.6 | | Ccn2 | 'Albumin Cre+/-;Hnf4a fl/fl' vs 'wild type genotype' | genotype | Transcription profiling by array of liver-specific Hnf4alpha knock-out mice |
1.6 | | Ccn2 | 'aortic banding' at '48 hour' vs 'sham' at '48 hour' | injury, time | Transcription profiling of heart ventricles from mice at different time points after surgical intervention for pressure-overload induced hypertrophy to identify differentially expressed genes. |
-1.6 | | Ccn2 | 'SARS coronavirus MA15 nsp16 -/-' vs 'SARS coronavirus MA15' at '7 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
-1.6 | | Ccn2 | 'CD47 knockdown; endothelial’ vs 'wild type; endothelial' | cell line, cell type, genotype | CD47 Inhibits Self-renewal and Reprogramming by Regulating c-Myc and Other Stem Cell Transcription Factors |
1.6 | | Ccn2 | 'NEMO knockout' vs 'wild type' | genotype | TNFR1 controls apoptosis and chronic liver disease in hepatocyte-specific IKKγ (Nemo) mice. |
1.6 | | Ccn2 | '21 month; SNCA knockout; striatum' vs '21 month; wild type; striatum' | age, genotype, organism part | Alpha-synuclein deficiency affects brain Foxp1 expression and ultrasonic vocalization |
1.6 | | Ccn2 | 'MyD88 homozygous knockout' vs 'wild type genotype' in 'TLR9 ligand CpG ODN (1826)' | genotype, stimulus | Transcription profiling by sequencing of murine MyD88 -/- and MyD88 +/+ mTECs stimulated with a TLR9 ligand |
-1.5 | | Ccn2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '14 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
1.5 | | Ccn2 | 'Sall4 homozygous knockout' vs 'wild type genotype' | genotype | RNA-Seq of Sall4 mutants in mouse embryonic stem cells |
-1.5 | | Ccn2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '60 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
1.5 | | Ccn2 | 'TGFβ withdrawal' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
1.5 | | Ccn2 | '8.5 millimolar; methoxyacetic acid' vs 'none' at '24 hour' | compound, time | Transcription profiling by array of mouse embryonic stem cells after treatment with 5-fluourouracil, methoxyacetic acid, monobutl phthalate, Penicillin G, retinoic acid or valproic acid |
1.5 | | Ccn2 | '3 day; osteogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn378' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
1.5 | | Ccn2 | '6 day; osteogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn378' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
1.5 | | Ccn2 | '6 day; osteogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn0' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
-1.5 | | Ccn2 | 'osteoblast culture 9 day' vs '0 day' | time | Transcription profiling by array of mouse primary neonatal osteoblasts to study the regulation of bone mineralisation |
1.5 | | Ccn2 | 'primary hair placode keratinocyte' vs 'interfollicular epidermal keratinocyte' | cell type | Transcription profiling of mouse primary hair placode keratinocytes compared to interfollicular epidermal keratinocytes |
-1.5 | | Ccn2 | 'lung carcinoma' vs 'normal' in 'CD11b+Ly6G+ neutrophil' | cell type, disease | Transcriptome analysis of isolated stormal cells and tumor epithelial cells in mouse lung cancer by RNA-Seq |
1.5 | | Ccn2 | 'adenoviral vector expressing human ACE2' vs 'empty adenoviral vector' | genotype | RNA-seq of SARS-CoV-2 infected lungs from mice sensitized for SARS-CoV-2 infection by Ad5-hACE2 transduction compared to non-sensitized mice |
-1.5 | | Ccn2 | 'early B-cell factor 1 overexpression' vs 'empty vector' at '0 day' | genotype, time | Transcription profiling by array of mouse NIH3T3 cells over-expressing PPARg pr EBF1 over time |
-1.5 | | Ccn2 | '1 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
1.5 | | Ccn2 | 'tamoxifen induction at 2 months, wait 1 months' vs 'no tamoxifen induction' in 'luminal cell of prostate epithelium; Nkx3.1-CreERT2 targeted allele' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
1.5 | | Ccn2 | 'UV' vs 'sham' in 'DMSO' at '6 hour' | irradiate, time | Transcription profiling by array of mouse dorsal skin exposed to UV radiation vs controls in mice treated with DMSO or selective tyrosine kinase inhibitor AG825 |
1.5 | | Ccn2 | 'wild type genotype; SARS MA15; 4 day' vs 'wild type genotype; mock' | genotype, infect, time | SARS infection of C57BL6, and PLAT knock-out mice |
-1.5 | | Ccn2 | 'doxycycline; 200 nanogram per milliliter; neoplasm; 5 day' vs 'none; normal; 0 day' | compound, phenotype, time | RNA-seq of doxycycline induced tumor and residual mouse primary mammary epithelial cells grown in 3D cell cultures against non-induced controls |
-1.5 | | Ccn2 | 'BIO' vs 'none' at '6 day' | age, compound | Transcription profiling of mouse embryonic stem cell line CGR8 during differentiation to mesenchymal stem cells and then adipocyte precursors |
-1.5 | | Ccn2 | 'CD2314 and BIO' vs 'none' at '6 day' | age, compound | Transcription profiling of mouse embryonic stem cell line CGR8 during differentiation to mesenchymal stem cells and then adipocyte precursors |
1.5 | | Ccn2 | 'inducible knockout of Rif1 (Rif1-/-)' vs 'wild type genotype' in '2 days cre induction' | genotype, growth condition | Gene expression profiles of Rif1 inducible knock-out embryonic stem cells |
1.5 | | Ccn2 | 'cardiotoxin; 40 microliter' vs 'none' in 'wild type' at '12 day' | compound, genotype, time | Transcription profiling by array of mouse skeletal muscle expressing CnAa or CnAb1 under the control of the MLC promoter after treatment with cardiotoxin |
1.5 | | Ccn2 | 'co-culture' vs 'separate' in 'wild type genotype' | genotype, growth condition | RNA-seq of wild-type and transformed Ink4a/Arf-/-; EGFRvIII neural stem cells in separate or co-culture conditions |
1.5 | | Ccn2 | 'SARS coronavirus MA15; 10^5 PFU' vs 'none' at '7 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
-1.5 | | Ccn2 | 'Trp53 Arg178Asp' vs 'wild type genotype' in 'dimethyl sulfoxide; 0.1 microliter' | compound, phenotype | Residual tumor suppressor activities of tumorigenic p53 mutants enhance survival under chemotherapy |
-1.5 | | Ccn2 | 'PKCzeta knock out' vs 'wild type' | genotype | Transcription profiling by array of hearts from PKCzeta knock out mice. |
-1.5 | | Ccn2 | 'cecal ligation and puncture surgery' vs 'sham surgery' in 'PPTA knockout' | clinical treatment, genotype | Gene expression profile in lung tissue 8 h after inducing polymicrobial sepsis in preprotachykinin-A (PPTA) knockout mice and wild type |
1.5 | | Ccn2 | 'utrophin/distrophin double knockout' vs 'distrophin knockout' in 'hindlimb muscle' | genotype, organism part | Transcription profiling of extraocular, hindlimb and cardiac muscles from dKO and MDX mice |
1.4 | | Ccn2 | 'Mettl6 knockout clone G6' vs 'wild type genotype' | genotype | METTL6 is a tRNA m3C methyltransferase that regulates translation and tumor cell proliferation |
1.4 | | Ccn2 | 'samarium doped cerium oxide nanoparticles; 4 day differentiated; 25 microgram per milliliter' vs 'none; 4 day differentiated' | compound, developmental stage | RNA-seq of C17.2 neuronal progenitor cells exposed to cerium oxide nanoparticles during cell differentiation |
1.4 | | Ccn2 | 'proliferating progenitor' vs 'differentiating progenitor' | cell type | Transcription profiling by high throughput sequencing of proliferating neural stem cells, differentiating neurogenic progenitors and newborn neurons using a dual-reporter mouse line |
-1.4 | | Ccn2 | 'extracellular vesicle; MET cell culture medium' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
-1.4 | | Ccn2 | '24 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine V6.5 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
-1.4 | | Ccn2 | 'MED23 knockout' vs 'wild type' | genotype | Mediator Med23-deficiency Enhances Neural Differentiation of Embryonic Stem Cells through Modulating BMP Signaling |
1.4 | | Ccn2 | 'subarachnoid hemorrhage' vs 'normal' | disease | Transcription profiling by array of the effect of SAH on brain cells in white matter region of mice |
-1.4 | | Ccn2 | 'interferon gamma; 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
1.4 | | Ccn2 | 'dominant-negative caPI3K transgenic' vs 'wild type' | genotype | Transcription profiling by array of transgenic mice with constitutively active PI3K or a dominant-negative form of PI3K |
1.4 | | Ccn2 | 'Gata4+/-' vs 'wild type genotype' in 'TAC-mediated heart pressure overload' | environmental stress, genotype | Transcription profiling of hearts from mice heterozygous for Gata4 mutation (G4D) to investigate the significance of Gata4 in regulating postnatal heart function and in regulating the hypertrophic response of the heart to pathological stress. |
1.4 | | Ccn2 | 'inducible knockout of Rif1 (Rif1-/-)' vs 'wild type genotype' in '4 days cre induction' | genotype, growth condition | Gene expression profiles of Rif1 inducible knock-out embryonic stem cells |
1.4 | | Ccn2 | '12 day' vs '5 day' in 'doxycycline; 200 nanogram per milliliter; neoplasm' | compound, phenotype, time | RNA-seq of doxycycline induced tumor and residual mouse primary mammary epithelial cells grown in 3D cell cultures against non-induced controls |
1.4 | | Ccn2 | 'InsR, Igf1R double knockout' vs 'wild type' in 'postnatal day 5' | developmental stage, genotype | Transcriptional profiling by array of mouse wild-type and Insulin receptor (InsR)/Igf1 receptor (Igf1R) double knockout mutant Sertoli cells from testis at embryonic day E17.5 and Postnatal day 5 |
-1.4 | | Ccn2 | 'acute oropharyngeal candidiasis wild type mice'; female' vs 'healthy wild type genotype mice' | compound, disease, genotype, sex | Transcription profiling by array of antibody blockade of IL-17-family cytokines in immunity to acute murine oral mucosal candidiasis |
1.4 | | Ccn2 | '2'-fucosyllactose supplementation' vs 'control' in '8 weeks post-ileocecal resection' | diet, treatment | Transcriptomic characterization of the impact of 2'-fucosyllactose supplementation on intestinal adaptation following ileocecal resection. |
1.4 | | Ccn2 | 'fasted' vs 're-fed' in 'wild type genotype; control miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1.4 | | Ccn2 | 'ERRalpha null mutant' vs 'wild type genotype' | genotype | Transcription profiling of mouse hearts from mutants lacking estrogen-related receptor alpha (ERRalpha), a nuclear receptor |
1.4 | | Ccn2 | '2 hour after induction of differentiation' vs 'induction of differentiation' | compound, sampling time point | Expression Profiling of Early Myogenesis - Affymetrix Dataset |
-1.4 | | Ccn2 | 'R6/2 transgenic' vs 'wild type' in '8 week; brain cortex' | age, genotype, organism part | Transcription profiling by high throughput sequencing in wild type and R6/2 mutant mouse cortex and striatum at 8 and 12 weeks. |
-1.4 | | Ccn2 | 'stabilization-competent' vs 'stabilization-incompetent' in '23 day; secondary reprogramming cell' | age, cell type, phenotype | Transcription profiling by high throughput sequencing in gene expresion profile of 4 SC clones and 4 SI clones at different time points defined a stabilization competency signiture |
1.4 | | Ccn2 | 'expression of a dominant negative form of MCU' vs 'wild type' in 'adult' | developmental stage, phenotype | mRNA Expression Changes Induced by Myocardial MCU Inhibition |
1.4 | | Ccn2 | 'aortic banding' at '1344 hour' vs 'sham' at '1344 hour' | injury, time | Transcription profiling of heart ventricles from mice at different time points after surgical intervention for pressure-overload induced hypertrophy to identify differentially expressed genes. |
1.4 | | Ccn2 | 'Tetrafluororethane; 50000 part per million; air' vs 'none; ; air' | compound, treatment | Transcription profiling by array of Mus musculus liver tissue after exposure to various carcinogenic chemicals |
-1.4 | | Ccn2 | 'Trp53 Arg178Asp' vs 'wild type genotype' in 'Nutlin-3a; 10 micromolar' | compound, phenotype | Residual tumor suppressor activities of tumorigenic p53 mutants enhance survival under chemotherapy |
-1.4 | | Ccn2 | '7 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-1.3 | | Ccn2 | 'Debaryomyces hansenii' at '6 hour' vs 'none' at '0 hour' | stimulus, time | RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls |
1.3 | | Ccn2 | 'CEBPa K159Q/K298Q expression' vs 'wild type CEBPa expression' | genotype | Transcriptome profiling of wild type, K159/298Q- and K159/298R- C/EBPα expressing mouse cells |
-1.3 | | Ccn2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '10 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
1.3 | | Ccn2 | 'overexpression of miR-25' vs 'wild type' | phenotype | Transcription profiling by high throughput sequencing of wild type and miR-25 agomir or antagomir treated mice |
-1.3 | | Ccn2 | '18 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine V6.5 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
1.3 | | Ccn2 | 'Mst1/2 knockout' vs 'control' | genotype | Microarray of Mst1/2 deleted epithelial cells from E18.5 mouse lungs |
-1.3 | | Ccn2 | 'HDAC1 knock out' vs 'wild type' | genotype | Transcription profiling by array of embryonic stem cells from wild type and histone deacetylase 1 (HDAC1) knock out mice |
1.3 | | Ccn2 | 'heart-specific Mdm2 knockout; 14 day' vs 'heart-specific Mdm2 knockout; 7 day' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
-1.3 | | Ccn2 | 'heart-specific p53 knockout; 28 day' vs 'wild type phenotype' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
1.3 | | Ccn2 | 'calorie restricted diet' vs 'normal diet' at '15 month' | age, diet | Transcription profiling by array of cochleae from mice fed a calorie-restricted diet |
1.3 | | Ccn2 | 'AZD8835; 50 milligram per kilogram' vs 'none' at '7 day' | compound, time | RNAseq of tumor samples from CT26 syngeneic mouse treated with a PI3Ka/d inhibitor (AZD8835) |
-1.3 | | Ccn2 | 'interleukin-1 beta (Mus musculus)' at '4 hour' vs 'control' at '4 hour' | stimulus, time | Genome-wide comparison between IL-17 and combined TNF-alpha/ IL-17 induced genes in primary murine hepatocytes |
-1.3 | | Ccn2 | 'brown adipose tissue' vs 'white adipose tissue' in 'chow; 23 degree celsius' | diet, organism part, temperature | RNA-seq of brown and white mouse adipose tissue at thermoneutrality and high-fat diet |
1.3 | | Ccn2 | 'PAI1 knockout; SARS MA15; 4 day' vs 'PAI1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
1.3 | | Ccn2 | 'SARS coronavirus MA15 E protein mutant Δ3' vs 'mock' | infect | Host responses contributing to the attenuation of severe acute respiratory syndrome coronaviruses missing E protein domains |
1.3 | | Ccn2 | 'liver specific SMARCB1 knockout' vs 'wild type' | phenotype | TP53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors |
1.3 | | Ccn2 | '130 week' vs '13 week' in 'liver' | age, organism part | Transcription profiling by array of liver, lung, spleen and kidney from young and old mice. |
-1.3 | | Ccn2 | 'adult definitive erythroid cell' vs 'primitive erythroid cell' in 'mix of orthochromatic and polychromatophilic erythroblast' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
1.3 | | Ccn2 | 'Gata4+/-' vs 'wild type genotype' in 'no pressure overload' | environmental stress, genotype | Transcription profiling of hearts from mice heterozygous for Gata4 mutation (G4D) to investigate the significance of Gata4 in regulating postnatal heart function and in regulating the hypertrophic response of the heart to pathological stress. |
-1.3 | | Ccn2 | 'SARS coronavirus MA15; 10^4 PFU' vs 'none' at '7 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
1.3 | | Ccn2 | 'overexpression of Foxd3' vs 'control' | phenotype | Expression data from embryonic stem cells differentiation |
-1.3 | | Ccn2 | 'KLF15 null' vs 'wild type genotype' in 'quadriceps skeletal muscle' | genotype, organism part | Transcription profiling of mouse livers and quadriceps muscles of Kruppel-like factor 15 (KLF15) null mutants after an overnight fast to provide insight into the role of KLF15 in gluconeogenesis |
1.3 | | Ccn2 | 'NEMO-TNFR1 double knockout' vs 'wild type' | genotype | TNFR1 controls apoptosis and chronic liver disease in hepatocyte-specific IKKγ (Nemo) mice. |
1.3 | | Ccn2 | 'Hnf1a knock out' vs 'wild type' | genotype | Transcription profiling of pancreatic islets from Hnf1a-deficient and wild type mice |
-1.3 | | Ccn2 | 'high fat diet' vs 'chow diet' in 'wild type' | genotype, growth condition | Transcription profiling of small heterodimer partner deficiency (SHP) knockout mice heart |
1.2 | | Ccn2 | 'Setd5 homozygous (null) knockout' vs 'Setd5 heterozygous knockout' | genotype | Transcriptional profiling of Setd5 heterozygous and knockout mouse embryonic stem cells |
-1.2 | | Ccn2 | 'interferon gamma' vs 'none' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
1.2 | | Ccn2 | 'Plasmodium berghei ANKA' at '7 day' vs 'none' at '0 day' in 'none' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
1.2 | | Ccn2 | 'transforming growth factor beta 1' vs 'none' at '1 day' | stimulus, time | Experimental overactivity or blockade of transforming growth factor-B each generate a specific ureter malformation |
-1.2 | | Ccn2 | '6 day; myogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn378' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
-1.2 | | Ccn2 | 'mutant (Pdgfc-/-; Pdgfra GFP/+)' vs 'control' | genotype | Cerebral gene expression changes in Pdgfc and Pdgfra mutant |
1.2 | | Ccn2 | '5-azacytidine 10 micromolar' vs 'none' | compound | Transcription profiling by array of mouse C2C12 cells treated with 5-azacytidine |
-1.2 | | Ccn2 | 'PF-04691502–resistant cell; 1 micromolar; PF-04691502' vs 'parental AKP cell; dimethyl sulfoxide' | compound, phenotype | Resistance to PI3K/mTOR inhibitor PF-04691502 in KRAS mutant colorectal cancer models reveals a sensitivity to combination with EGFR inhibition |
1.2 | | Ccn2 | 'Pkhd1Cre; Pkd2 F/F' vs 'wild type' | genotype | Next Generation Sequencing of PKD2 mutant mice kidneys |
1.2 | | Ccn2 | 'Yin Yang 1 (YY1) knockout' vs 'wild type' | genotype | Expression data from mouse skeletal muscle |
-1.2 | | Ccn2 | 'rosiglitazone; 100 nanomolar' vs 'none' in 'wild type genotype' | compound, genotype | Transcriptional response to Rosiglitazone in adipocyte progenitors isolated from WT and Cited4-KO scWAT |
1.2 | | Ccn2 | 'Pkhd1Cre; Pkd2 F/F; miR-21null' vs 'wild type' | genotype | Next Generation Sequencing of PKD2 mutant mice kidneys |
-1.2 | | Ccn2 | 'ATF3 -/-' vs 'wild type' in '10 nanogram per milliliter; lipopolysaccharide' at '2 hour' | compound, genotype, time | Transcription profiling by array of mouse bone marrow macrophages mutant for ATF3 after treatment with lipopolysaccharide |
1.2 | | Ccn2 | 'tamoxifen induction at 2 months, wait 3 months' vs 'no tamoxifen induction' in 'luminal cell of prostate epithelium; Nkx3.1-CreERT2 targeted allele' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
1.2 | | Ccn2 | 'Staphylococcus aureus Sanger476; 2 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.2 | | Ccn2 | 'Porphyromonas gingivalis; normal' vs 'normal' | infect, phenotype | hyperlipidemia impaired innate response |
1.2 | | Ccn2 | 'postnatal day 12' vs 'postnatal day 1' in 'insulin-expressing immature beta cell' | cell type, developmental stage | Transcription profiling by high throughput sequencing of murine beta cells at key stages of maturation |
1.2 | | Ccn2 | 'NeuroD1 conditional knockout' vs 'control' in 'retina' at 'Zeitgeber time 20' | genotype, organism part, sampling time point | Gene expression profile of retina and pineal gland of NeuroD1 conditional knockout mice |
-1.2 | | Ccn2 | 'SARS coronavirus MA15' vs 'none' in 'STAT1 -/-' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
1.2 | | Ccn2 | 'fasted' vs 're-fed' in 'db/db; control miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1.2 | | Ccn2 | 'anti-mPDL1; anti-mCTLA4; 10 milligram per kilogram' vs 'none' at '7 day' | compound, time | RNAseq of tumor samples from CT26 syngeneic mouse treated with a PD-L1 and CTLA-4 immunotherapy combination |
1.2 | | Ccn2 | 'Sall4 -/-' vs 'wild type genotype' | genotype | RNA-Seq of mouse embryonic stem cells in response to changes in Sall4 |
1.2 | | Ccn2 | 'neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | Transcription profiling by array of Apc+/Delta716 mouse intestinal polyps vs normal intestinal mucosa |
-1.2 | | Ccn2 | 'miR-1-133a_OSMR_tKO' vs 'miR-1-133a_dKO' | compound, genotype | Repression of OSMR and FGFR1 by miR-1/133a prevents adult cardiomyocyte dedifferentiation and cell cycle entry in the adult heart |
-1.2 | | Ccn2 | 'PgrCre/+ Foxa2flox/flox' vs 'wild type' | genotype | Identification of candidate FOXA2-regulated genes in the adult mouse uterus |
1.2 | | Ccn2 | 'conditional Kras and p53 mutation induced soft tissue sarcoma' vs 'normal' | disease | Transcription profiling by array of mouse soft tissue sarcoma samples induced by conditional mutations of Kras and p53 against healthy muscles from mice of the same genotype but no induced sarcoma |
1.2 | | Ccn2 | 'Malathion; 14800 part per million; rodent chow' vs 'none; ; rodent chow' | compound, treatment | Transcription profiling by array of Mus musculus liver tissue after exposure to various carcinogenic chemicals |
1.2 | | Ccn2 | 'Hnf1a heterozygous mutant' vs 'wild type genotype' | genotype | Transcription profiling by array of pancreatic islets from pancreas-specific Hnf4alpha knockout, heterozygous Hnf1alpha, and double mutant mice |
1.1 | | Ccn2 | 'KRas siRNA' vs 'non-targeting siRNA' | RNA interference | RNA-SEQ analysis of KMC murine pancreatic ductal adenocarcinoma (PDAC) cell line upon siRNA depletion of MYC, KRas or Miz1 (aka Zbtb17) |
-1.1 | | Ccn2 | 'Debaryomyces hansenii' at '12 hour' vs 'none' at '0 hour' | stimulus, time | RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls |
1.1 | | Ccn2 | 'RAM siRNA' vs 'control' in 'cytoplasmic RNA' | RNA interference, protocol | Transcription profiling by high throughput sequencing of mouse 46C embryonic stem cells transfected with RAM siRNA or control |
1.1 | | Ccn2 | 'samarium doped cerium oxide nanoparticles; 7 day differentiated; 25 microgram per milliliter' vs 'none; 7 day differentiated' | compound, developmental stage | RNA-seq of C17.2 neuronal progenitor cells exposed to cerium oxide nanoparticles during cell differentiation |
-1.1 | | Ccn2 | 'ATF5 knockdown' vs 'wild type' in 'DMSO' | compound, genotype | Microarray to find ATF5 dependent genes in response to proteasome inhibition |
1.1 | | Ccn2 | 'IRAK1BP1 KO' vs 'wild type' in 'none' | genotype, treatment | Identification of TNFα-induced genes that are IRAK1BP1 dependent |
1.1 | | Ccn2 | 'PH3 homozygous knockout' vs 'wild type phenotype' | phenotype | PHF3 binds RNA polymerase II via the SPOC domain and regulates transcription of neuronal genes - Mouse Embryonic Stem Cell RNAseq |
-1.1 | | Ccn2 | '3 day; myogenesis differentiation' vs ' 0 day; control' in '2C12-pMirn0' | cell line, growth condition, time | Effect of Mirn378 overexpression on gene expression during C2C12 myogenic and BMP2-induced osteogenic differentiation |
-1.1 | | Ccn2 | 'Triple knockout (Zfp36-/-, TNFR1-/-, TNFR2-/-)' vs 'wild type' | genotype | Transcription profiling by high throughput sequencing of douple (TNFR1-/-/TNFR2-/-) and triple (Zfp36-/-/TNFR1-/-/TNFR2-/-) knockout mouse spleens |
1.1 | | Ccn2 | '1810027O10Rik knockout; abdominal muscle' vs 'wild type genotype; abdominal muscle' | genotype, organism part, sampling site | RNAseq of coding RNA in the liver, spleen, kidney, abdominal muscle and gonadal adipose tissue of knock out mice and wild type controls. |
1.1 | | Ccn2 | 'FVBNCr; RML infected' at '20 week' vs 'FVBNCr; uninfected' at '20 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
1.1 | | Ccn2 | 'SARS coronavirus MA15' vs 'none' at '4 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
1.1 | | Ccn2 | 'IRAK1BP1 KO' vs 'wild type' in 'TNFα' | genotype, treatment | Identification of TNFα-induced genes that are IRAK1BP1 dependent |
1.1 | | Ccn2 | 'phosgene - carbonyl chloride' at '8 hour' vs 'none' at '0 hour' | compound, time | Transcription profiling of lung from mouse exposed to carbonyl chloride (phosgene) for different lengths of time to investigate the molecular mechanism of phosgene-induced lung injury |
1.1 | | Ccn2 | 'upf3 knockout' vs 'wild type' in 'testis' | cell type, genotype | UPF2 establishes testis-specific transcriptome enriched in transcripts with shorter 3’UTRs |
-1.1 | | Ccn2 | 'HDM allergen; IL-13 knockout' vs 'HDM allergen; wild type' on 'Affymetrix MOE430A Array' | compound, genotype | Transcription profiling of wild type and IL13 knock out mice treated with allergen vs. control to investigate the IL13 role in allergic asthma |
-1.1 | | Ccn2 | 'heart-specific p53 knockout; 7 day' vs 'wild type phenotype' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
1.1 | | Ccn2 | 'doxycicline-mediated expression of c-Jun' vs 'control' | phenotype | Transcription profiling by array of mouse whole bone marrow after c-Jun induction |
1.1 | | Ccn2 | '0.5 hour after induction of differentiation' vs 'induction of differentiation' | compound, sampling time point | Expression Profiling of Early Myogenesis - Affymetrix Dataset |
-1.1 | | Ccn2 | 'Trypanosoma brucei STIB247' vs 'uninfected' | infect | Transcription profiling by array of spleens from mice infected with different Trypanosoma brucei strains |
1.1 | | Ccn2 | 'heart-specific p53 and Mdm2 knockout; 7 day' vs 'heart-specific p53 and Mdm2 knockout; 1 day' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
1.1 | | Ccn2 | 'epithelium-specific Apc; Bcl9; Bcl9l knockout' vs 'wild type' | phenotype | RNAseq of murine small intestinal tissue following epithelium-specific deletion of Bcl9/9l +/- Apc +/- mutant B-catenin |
1.1 | | Ccn2 | 'TGF-beta; 15 nanogram per milliliter' vs 'control' | compound | TGF beta Dosage Experiment |
-1.1 | | Ccn2 | 'PGC-1 beta knock in' vs 'wild type' | genotype | Transcription profiling by array of skeletal muscle from PGC-1 beta transgenic mice |
-1.1 | | Ccn2 | 'SARS coronavirus MA15' vs 'none' in 'wild type genotype' at '7 day' | genotype, infect, time | SM020 - Infection with SARS MA15 of C57BL/6J mice and KEPI (ppp1r14c) knockouts |
1.1 | | Ccn2 | 'transgenic C3(1)-SV40Tag; 16 week' vs 'wild type; 8 week' | age, genotype | Prevention of mammary tumor progression by silencing HoxA1 via intraductal injection of nanoparticle-formulated siRNA |
-1.1 | | Ccn2 | 'Mycobacterium tuberculosis; D2.B6-Chr7 congenic; 70 day' vs 'control; D2.B6-Chr7 congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
-1.1 | | Ccn2 | 'tumor necrosis factor-alpha/interleukin-17 (Mus musculus)' at '4 hour' vs 'control' at '4 hour' | stimulus, time | Genome-wide comparison between IL-17 and combined TNF-alpha/ IL-17 induced genes in primary murine hepatocytes |
-1.1 | | Ccn2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'PWK/PhJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1.1 | | Ccn2 | 'intestinal smooth muscle culture supernatant' vs 'none' in 'organoid culture without Noggin (ER medium)' | growth condition, stimulus | RNA-seq of small intestinal organoids treated with the control medium ENR (EGF, Noggin, R-spondin1) in the presence or absence of muscle supernatant |
-1.1 | | Ccn2 | 'Mycobacterium tuberculosis; D2.B6-Chr19 congenic; 70 day' vs 'control; D2.B6-Chr19 congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
-1.1 | | Ccn2 | 'SARS coronavirus MA15' vs 'none' in 'Tnfrsf1a/1b -/-' at '4 day' | genotype, infect, time | SM019 - Infection with SARS MA15 of C57BL/6J mice and Tnfrsf1b knockout mice |
-1.1 | | Ccn2 | '14 day' vs '7 day' vs 'anti-mPDL1; anti-mCTLA4; 10 milligram per kilogram' | compound, time | RNAseq of tumor samples from CT26 syngeneic mouse treated with a PD-L1 and CTLA-4 immunotherapy combination |
1.1 | | Ccn2 | 'Wnt1Cre Ezh2lox/lox' vs 'control' | genotype | Expression data from E11.5 mouse branchial arch 1 (BA1) - comparison between Ezh2lox/lox and Wnt1Cre Ezh2lox/lox embryos |
-1.1 | | Ccn2 | 'Abcc8-/-' vs 'wild type genotype' in 'normal; female' | diet, genotype, sex | Effects of increased intracellular calcium and overnutrition on pancreatic beta cell transcriptome |
-1.1 | | Ccn2 | 'missense mutation (T2996C) in Mucin 2 (Muc2)' vs 'wild type genotype' | genotype | Transcription profiling of mouse intestine in ENU mutagenesis mouse strains with missense mutations in Muc2 mucin and ER stress |
1.1 | | Ccn2 | 'transgenic C3(1)-SV40Tag; 12 week' vs 'wild type; 8 week' | age, genotype | Prevention of mammary tumor progression by silencing HoxA1 via intraductal injection of nanoparticle-formulated siRNA |
1.1 | | Ccn2 | 'Ghrh-KO' vs 'wild type' | genotype | Gene expression in liver tissue from Ghrh-KO and normal (wild-type) mice |
1.1 | | Ccn2 | 'trichostatin A and LIF' at '6 hour' vs 'none' at '0 hour' | compound, time | Transcription profiling of mouse embryonic stem cell line CGR8 grown in presence of Leukemia Inhibitory Factor and treated with trichostatin A |
-1.1 | | Ccn2 | 'L-Arginine' vs 'water' in 'dextran sodium sulphate induced colitis' | compound, disease | Transcription profiling by array of murine colon tissue after exposure to 4% dextran sodium sulphate (DSS) for 6 days followed by 4 days of water or 1% L-arginine to study the effect of L-arginine on DSS-induced colitis |
1.1 | | Ccn2 | 'H9; undifferentiated 3factor-reprogrammed induced pluripotent stem cell' vs 'R1; undifferentiated embryonic stem cell' at '0 day' | cell line, growth condition, time | Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines |
1.1 | | Ccn2 | 'TIMP1 knockout; SARS MA15; 4 day' vs 'TIMP1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
-1.1 | | Ccn2 | 'tristetrapolin knockout' vs 'wild type' in 'actinomycin D' at '120 minute' | compound, genotype, time | Transcription profiling by array of fibroblasts from TTP knock out mice |
1.1 | | Ccn2 | '8 week' vs '4 week' | age | Differential gene expression in the Lacrimal gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. |
1.1 | | Ccn2 | 'miR-1-133a_dKO' vs 'wild type genotype' | compound, genotype | Repression of OSMR and FGFR1 by miR-1/133a prevents adult cardiomyocyte dedifferentiation and cell cycle entry in the adult heart |
1.1 | | Ccn2 | 'permanent neonatal diabetes mellitus' vs 'normal' | disease | Microarray comparing gene expression changes between control, normoglycaemic mice, and mice expressing the human neonatal diabetes mutation Kir6.2-V59M in pancreatic beta-cells left diabetic for 2 weeks |
-1.1 | | Ccn2 | 'fetal definitive erythroid cell' vs 'primitive erythroid cell' in 'mix of orthochromatic and polychromatophilic erythroblast' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
1 | | Ccn2 | 'MYC siRNA' vs 'non-targeting siRNA' | RNA interference | RNA-SEQ analysis of KMC murine pancreatic ductal adenocarcinoma (PDAC) cell line upon siRNA depletion of MYC, KRas or Miz1 (aka Zbtb17) |
1 | | Ccn2 | 'Zbtb2 -/-' vs 'wild type genotype' in 'SerumLIF' at '2 day' | genotype, growth condition, time | RNA-seq for wild-type and Zbtb2 knock-out clones of mESCs in 2iLIF, EpiLC and SerumLIF conditions. |
-1 | | Ccn2 | 'interferon gamma' vs 'none' in 'dexamethasone; 100 nanomolar' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
-1 | | Ccn2 | '48 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine V6.5 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
-1 | | Ccn2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '30 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
1 | | Ccn2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'A/J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1 | | Ccn2 | 'transverse aortic constriction' vs 'sham transverse aortic constriction' | treatment | Transcriptional profiling of mouse heat left ventricle after dfferential cardiac remodeling in preload versus afterload. |
-1 | | Ccn2 | 'PR knockout' vs 'control' | genotype | Expression data from progesterone receptor knockout versus heterozygous mouse oviducts |
-1 | | Ccn2 | 'GW501516' at '48 hour' vs 'none' | compound, time | PPARd target genes in MEFs |
-1 | | Ccn2 | 'actinomycin D; 4 hour' vs 'none' in 'Alb-Cre-ERT2 / Cnot1 flox/flox' | compound, genotype, time | RNA-seq of livers in control and Cnot1 tamoxifen-inducible liver-specific knockout mice |
1 | | Ccn2 | 'undifferentiated' vs 'differentiated; rosiglitazone' in 'F1.129xB6' | phenotype, stimulus, strain | RNA-seq of mouse subcutaneous SVF cells before and after differentiation with a brown fat differentiation cocktail |
-1 | | Ccn2 | '5,9-endoperoxy-cholest-7-en-3β,6α-diol' vs 'vehicle (cyclodextrin)' | compound, time | Array results for differential gene expression in 661W, a mouse cone photoreceptor-derived cell line, comparing cells incubated with vehicle controls vs. those treated with either of two 7-dehdyrocholesterol-derived oxysterols or cholesterol |
1 | | Ccn2 | 'recombinant growth differentiation factor 11; 100 nanogram per milliliter' vs 'vehicle' | compound | Transcription profiling by array of mouse bone marrow-derived macrophages treated with recombinant growth differentiation factor 11 (rGDF11) |
1 | | Ccn2 | 'hepatocyte-derived proliferative ducts (hepPDs)' vs 'biliary-derived proliferative ducts (bilDP)' | cell type | Transcription profiling by high throughput sequencing of hepatocyte-derived progenitors cells in a mouse model of oval cell activation |
1 | | Ccn2 | '19 month' vs '4 month' in 'C/EBPβ-ΔuORF expression' | age, genotype | Transcriptome profiling of liver samples of C/EBPß ∆uORF mice |
-1 | | Ccn2 | 'transgenic' vs 'wild type' in '160 day; C57BL/6' | age, genotype, strain | Whole genome transcriptome analysis identifies indices of fast and slow disease progression in two ALS mouse models |
1 | | Ccn2 | 'Med1 knockout' vs 'wild type' in 'ventral prostate' | genotype, organism part | Changes in gene expression caused by loss of Med1 in the mouse prostate |
1 | | Ccn2 | 'db/db' vs 'wild type genotype' in 'Gabpa miRNA; re-fed' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1 | | Ccn2 | 'phenylephrine; 30 milligram per kilogram per day' vs 'vehicle' | compound | RNA-seq of myocytes from mice treated in vivo for 3 days with vehicle, angiotensin II, or phenylephrine |
1 | | Ccn2 | 'InsR, Igf1R double knockout' vs 'wild type' in 'embryonic day 17.5' | developmental stage, genotype | Transcriptional profiling by array of mouse wild-type and Insulin receptor (InsR)/Igf1 receptor (Igf1R) double knockout mutant Sertoli cells from testis at embryonic day E17.5 and Postnatal day 5 |
-1 | | Ccn2 | 'heart-specific Mdm2 knockout; 7 day' vs 'wild type phenotype' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
-1 | | Ccn2 | 'STAT1 -/-' vs 'wild type genotype' in 'SARS coronavirus MA15' at '9 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
1 | | Ccn2 | 'mutant MyoD expression' at '12 hour' vs 'control' at '12 hour' | phenotype, time | Transcription profiling of mouse embryoic fibroblasts expressing wild type MyoD or its non-acetylatable version MyoD RRR to investigate how MyoD acetylation may contribute to differential gene activation. |
-1 | | Ccn2 | 'rosiglitazone; 100 nanomolar' vs 'none' in 'Cited4-/-' | compound, genotype | Transcriptional response to Rosiglitazone in adipocyte progenitors isolated from WT and Cited4-KO scWAT |
-1 | | Ccn2 | 'dinitrofluorobenzene' vs 'control' in 'Cnr1 -/- /Cnr2 -/-' | compound, genotype | Transcription profiling of mouse Cannabinoid receptor double knockouts (Cnr1 -/- /Cnr2 -/-) in CHS model to investigate cutaneous contact hypersensitivity |
1 | | Ccn2 | '10 microgram; ovalbumin' vs 'none' in 'RAG null mutant' | compound, genotype | Transcription profiling by array of lungs from mice mutant for RAG after challenge with ovalbumin |
1 | | Ccn2 | 'RAM siRNA' vs 'control' in 'polysomal RNA' | RNA interference, protocol | Transcription profiling by high throughput sequencing of mouse 46C embryonic stem cells transfected with RAM siRNA or control |
1 | | Ccn2 | 'Alb-Cre;HIF1dPA' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
1 | | Ccn2 | 'dysferlin mutant' vs 'wild type' in 'left ventricle cardiac muscle' | genotype, organism part | Transcription profiling by array of skeletal and cardiac muscle from dysferlin-deficient mice |
1 | | Ccn2 | 'Crx knockout' vs 'control' at '6 zeitgeber' | genotype, time | Transcriptome in 129sv and Crx-/- pineal gland at ZT (Zeitgeber time) 6 and ZT20 |
1 | | Ccn2 | 'HP1g knockdown' vs 'control' in 'embryoid body' | developmental stage, genotype | Transcription profiling of mouse embryonic stem cell line CGR8 transfected with control shRNA and shRNA against HP1g in two different developmental stages |
-1 | | Ccn2 | '6 week' vs '0 week' | time | Transcription profiling by array of mouse colon tissues with T cell transfer-induced colitis at week 0, 2, 4 and 6 post-transfer |
1 | | Ccn2 | 'CCl4; 1.6 gram per kilogram' at '48 hour' vs 'none' at '0 hour' | compound, time | Transcriptional responses in liver upon acute CCl4 intoxication |
1 | | Ccn2 | 'transverse aortic constriction' vs 'sham surgery' at '10 day' | clinical treatment, time | Transcription profiling of mouse gene expression after transverse aortic constriction in mice: comparison of TAC vs. sham group at 2, 10 and 21 days to identify the differential expression of genes |
-1 | | Ccn2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'PWK/PhJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1 | | Ccn2 | 'Gabpa miRNA' vs 'control miRNA' in 'db/db; re-fed' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1 | | Ccn2 | 'Ela-Tgfa' vs 'wild type' | genotype | Transcription profiling by array of pancreas from KrasG12D, Ela-Tgfa and KrasG12D Ela-Tgfa mice |
1 | | Ccn2 | 'prednisolone; dimerization-defective glucocorticoid receptor' vs 'vehicle; dimerization-defective glucocorticoid receptor' | compound, genotype | Prednisolone-induced differential gene expression in liver of mice carrying the wild type or a dimerization-defective glucocorticoid receptor |
1 | | Ccn2 | 'UV' vs 'sham' in 'AG825' at '6 hour' | irradiate, time | Transcription profiling by array of mouse dorsal skin exposed to UV radiation vs controls in mice treated with DMSO or selective tyrosine kinase inhibitor AG825 |
1 | | Ccn2 | 'Ezh2f/f;Mef2cAHF::Cre knockout' vs 'Ezh2f/f wild type' | genotype | Transcription profiling by array of mouse heart mutant for Ezh2 |
1 | | Ccn2 | 'control mice [Gp130f/f]; cecal ligation and puncture' vs 'control mice [Gp130f/f]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
1 | | Ccn2 | 'SARS coronavirus MA15; 10^5 PFU' vs 'none' at '1 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
-1 | | Ccn2 | '120 day; Sod1 G93A' vs '120 day; wild type genotype' | age, genotype | Transcription profiling of astrocytes from the symptomatic and late-stage time points of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis (ALS) |
-1 | | Ccn2 | '2% curcumin' vs 'control' in 'trinitrobenzene sulfonic acid-induced experimental colitis' on 'Affymetrix MOE430A' | diet, disease | Transcription profiling by array of colon tissues from mice with or without trinitrobenzene-sulfonic acid induced colitis fed on standard diet or on anti-inflammatory compound Curcumin |
-1 | | Ccn2 | 'SARS coronavirus MA15; 10^3 PFU' vs 'none' at '7 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
-1 | | Ccn2 | 'doxorubicin; 15 milligram per kilogram; CHIP knockout' vs 'doxorubicin; 15 milligram per kilogram; wild type' | compound, genotype | Expression data from DOX(doxorubicin) -treated wild type or CHIP knockout C57BL/6J mice at day 5 |
-1 | | Ccn2 | 'embryoid body' vs 'embryonic stem cell' on 'Affymetrix GeneChip Array 430A 2.0' | developmental stage | Gene expression profile of J1 embryonic stem cells and J1 embryoid bodies |
1 | | Ccn2 | 'homozygous conditional dicer1 knockout' vs 'wild type genotype' in 'P7 forebrain Aldh1l1-EGFP positive cell' | cell type, genotype | Transcription profiling by array of wild-type or homozygous dicer1 conditional knockout forebrain P7 Aldh1l1-EGFP cells and Ald1l1-EGFP positive primary astrocytes |
1 | | Ccn2 | '4 hours after hCG treatment' vs 'control' in 'wild type' | genotype, treatment | The ISWI ATPase Snf2L is required for superovulation and regulates Fgl2 in differentiating mouse granulosa cells |
1 | | Ccn2 | 'liver-specific Pit1 knockout' vs 'wild type genotype' in 'regular chow diet' | diet, genotype | Transcription profiling by array of liver tissues from mice with liver-specific knockout of Pit1 and wild-type littermates fed with either a high-fat diet or chow control diet |
1 | | Ccn2 | 'oscillating fluid flow' vs 'sham' at '2 hour' | time, treatment | Integrative transcriptomic and proteomic analysis of osteocytic cells exposed to fluid flow reveals novel mechano-sensitive signaling pathways |